iPierian
South San Francisco, California, United States
About iPierian
We are using induced pluripotent stem cells for drug discovery and development. Focused on neurodegenerative diseases such as SMA, ALS and Parkinson's, and other major unmet medical needs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $80.7M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2017)
- Website: ipierian.com
- Phone: 650-872-4700
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ipierian-2481232 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.